Sean Duffy

Some VC investors believe that brick and mortar - referring to a physical presence of some kind - should be avoided at all costs. Yet, the track record of clinic and hybrid care businesses in health care indicates otherwise. ==> One Medical (sold for $3.9 billion to Amazon), Oak Street (bought by CVS for $10.6 billion), Lifestance (IPO at $7.5 billion market cap), and PE-backed Premise Health (acquired by OMERS Private Equity for $1.1 billion) If a clinic is indicated as the optimal way to deliver care for that patient population, there are creative ways to build and operate them. Full article below with advice and strategies on how to build and operate hybrid clinics from my teammate Anarghya Vardhana from Maveron, Amir Dan Rubin from OneMedical Group, Steven Eidelman from Modern Animal and more!

13

1 Comment

Someone broke down the estimated costs of a $15 Sweetgreen salad. We need these cost graphics for digital health to help future founders. Especially for tech enabled cos, the greatest cost is labor. Much of the "value created" is in curation and matching, which means the gross margins are reliant on labor arbitrage. Pay someone $X, but get paid $X+Y% per visit. The challenge with healthcare is that you often have to pick one of two business models: 1. specialized, low volume, high cost, low gross margin % 2. generalized, high volume, low cost, high gross margin % I'd argue founders should focus on gross dollars over the lifetime of the customer (like Jeff Bezos said) instead of gross margin %'s, but we'll leave that for another time. The challenge is that many tech enabled digital health cos have high cost of goods sold (labor) and moderately high product, design, and engineering budgets. We must build differentiated solutions for patients, clinicians, and clients to be out incumbents, however, we're realizing that companies are ultimately valued on the discounted value of future cash flows. And the high SG&A costs at most organizations might be inbalanced to the unit economics of the business. I'm not sure the math pencils out for everyone unfortunately. But I'm just a guy on the internet, would love to hear the thoughts from those smarter than I (you!). Comment below. --- p.s. I have no idea the accuracy of the graphic and not an investor in Sweetgreen. Cheers. Credit: David Crowther

112

27 Comments

"Digital health is no longer the future; it is the present, reshaping our healthcare landscape in real-time." Excited to be part of the UCSF Digital Health Hub Foundation's Quarterfinalist Party! As a past board member, I'm honored to celebrate the outstanding quarterfinalists. As we reflect on the state of digital health in 2024, it's evident that the COVID-19 pandemic has fundamentally transformed healthcare delivery. The rapid adoption of telemedicine during the crisis has become a permanent fixture, with over 60% of physicians continuing to utilize this technology. The sprint towards smarter healthcare, catalyzed by necessity, has shattered preconceptions about digital-first health experiences. Virtual care is no longer a stopgap but an integral part of a seamless, anytime, anywhere health ecosystem. 🌍 We're witnessing the rise of B2B2C models in remote consultations, with companies like Teladoc Health and Amwell partnering with insurance providers to integrate their services into health plans. Public sector collaborations, like eConsult Health 's partnership with the NHS in the #UK, underscore the potential for remote consultations to enhance efficiency and accessibility at a national level. The digital health landscape is evolving rapidly, with advancements in remote consultations, mental health support, at-home diagnostics, and patient monitoring. AI and generative AI transform care delivery, making it more efficient, personalized, and patient-centric. 🤖 Yet, challenges remain. While venture capital funding for digital health has stabilized after the pandemic boom, it remains below its 2021 peak. Sectors like digital therapeutics face reimbursement hurdles, and we've seen major players like Walmart and Optum close telehealth businesses. Looking ahead, we anticipate further consolidation in digital health, driven by acquisitions to create broader ecosystems encompass telemedicine, mental health, and other specialized services. As healthcare leaders, we must leverage these digital advancements to improve access, enhance patient outcomes, and drive efficiency in our healthcare systems. The future of healthcare is digital, and the time to embrace this transformation is now. Congratulations to all the finalists! 🎉 Looking forward to the grand finale at #HLTH2024 in #LasVegas! 🙌 By the way, the pink drink that we were holding was delicious—and nonalcoholic! The Digital Health Hub Foundation - Digital Health Awards #HealthcareInnovation #DigitalHealth #UCSFHealthHub #Networking #HealthTech #Entrepreneurship #LasVegasFinale Walter Greenleaf, PhD Daniel Kraft, MD Unity Stoakes StartUp Health University of California, San Francisco UCSF Innovation Ventures American Association for Precision Medicine (AAPM) WISE World Investors & Entrepreneurs Society #AAPMhealth #aapm_health

94

7 Comments

Had a blast diving into Amir Dan Rubin's extensive healthcare career on Vital Signs. Amir previously served as the CEO of One Medical and Stanford Health Care, was an EVP at United/Optum and is now the Founding Managing Partner at Healthier Capital. Our conversation spanned payer-provider integrations, lessons learned from leading One Medical, applications of generative AI, and more. Some highlights: ⚡Combining care models We talked a lot about the One Medical/Iora combination. Amir argues that just because two care delivery approaches may occupy the same physical location (e.g., a clinic), that doesn’t mean they necessarily need to conform to the same economic model. For instance, One Medical and Iora were able to combine effectively despite the former being a membership model and the latter being global capitation. Amir emphasizes that much of the overhead resources (e.g., front desk staff, phlebotomy) can be shared across models. ⚡How One Medical uses generative AI to improve efficiency One Medical allows members to message the care team, and then uses NLP to read the message, figure out its content, and triage it to the appropriate team member. Amir is excited about leveraging internal knowledge graphs to get around hallucinations. This approach can point to relevant internal data in helping compose responses, creating more trust and accuracy in the outputs. ⚡Behind the Amazon acquisition One Medical was interested in expanding its direct to consumer offering. However, they recognized that customer acquisition was costly, which is why partnering with Amazon Prime’s existing membership base made sense for them. Amir explains how at their core, both Amazon and One Medical are all about using technology and logistics to create an excellent customer experience. An awesome conversation ranging from health system innovation to startup strategy to health tech investing! Listen to our full episode below: Spotify: https://spoti.fi/3Wrbnol Apple: https://apple.co/3XWOomb

129

7 Comments

Exciting news from Monica Chopra, Jeffrey De Flavio, MD, Samantha Adelberg, and the rest of the Auxa Health team as they officially announce their $5.2M Seed round. The team's deep industry expertise and drive for change have led them to solve critical infrastructural friction to providing quality healthcare and adoption of value-based care. Auxa's AI benefit navigation platform is simplifying the complexities of healthcare by streamlining all of the fragmented and siloed data and information to make it actionable in real-time for healthcare organizations. For the 70% of Americans who aren't getting access to the health and social care benefits they deserve, Auxa's solution will be pivotal in enabling equitable care. We're thrilled to partner with co-investors Zeal Capital Partners, AlleyCorp, Laconia, and Chaac Ventures on this journey and look to share many more milestones ahead. Cc K50 Ventures, Ryan Bloomer, Daniel Vásquez, Nick Talwar, Stefanie Ng https://lnkd.in/dPDY7-Db

44

4 Comments

Hot take on a lot of early-stage digital health companies out there: You're not a tech company. Most tech-enabled care companies I've seen over the past two years are only tech-enabled in the sense that they use telehealth as their delivery mechanism for care. There are exceptions to this, of course - companies who build computer vision and applied AI tools to better the doctor-patient experience, companies who build tooling around risk scoring and stratification to enable more personalized medicine, companies who build truly novel intakes to better route patients to the appropriate care, etc. These companies have real technology chops and, if they sell it right to the market, can get credit for this from investors. But if you're truly a telehealth provider, you need to realize now that the goal post has shifted dramatically from 2021 and you're going to be valued at maturity at something like 3x EBITDA. That's profit. Not revenue. Throw a revenue multiple out the window. That's not the world we live in if you're a virtual doctor's office. Think of how that impacts venture math. If you're raising a seed round at $15M post-money (or $12M pre-money), it means you'll have to generate something like $150-200M in annual EBITDA to be a fund returner for your seed investors. Maybe even more with dilution, since telehealth businesses are not traditionally capital efficient and will likely need to raise material additional capital to reach that scale. You need to be ridiculously profitable (probably on $800M-$1B in annual revenue since you're likely going to be a 40% gross margin business). Here's the good news: you can set yourself up well (and probably be a contrarian founder relative to your peers), by talking about EBITDA growth and how you can grow into a fund-returning outcome based on realistic mature market comps. This will stand out for the investors you're pitching, even at the early stage. This is how you can beat the malaise of the tech-enabled care market. Focus on the right metrics and the right type of growth. You don't have to have all the answers (no founder does), but you need to make sure the ship is headed in the right direction. A focus on profitability for "tech-enabled care" (*ahem* telehealth) businesses is a good first step.

26

3 Comments

Investing in companies that fill needs for health systems is a growth opportunity for both delivery organizations and start ups. Some systems are jumping in on their own, while others are partnering with like minded systems or with established VC firms. While this is a relatively new trend for systems, health plans have been making similar bets for many years. The benefits of becoming a health system portfolio company can be significant. Data, access to beta populations and real world coaching can be extremely beneficial. Start ups get mentoring and systems have to ability to leverage outside resources to solve relevant business problems. I predict a booming business!

4

M13 is thrilled to lead the Series A in RadiantGraph which is focused on personalization in healthcare. As we continue to invest in early stage companies it is abundantly clear that the biggest indicator of success is the founder and his or her ability to execute on their vision of the future. In this case, I don't think I have seen much better founder-market fit than we have with founder and CEO Anmol Madan. We believe in his vision: in order to have the best patient outcomes in healthcare we need increased personalization and AI is the breakthrough to get us there. Anmol started one of the pioneering digital health companies Ginger and then was Chief Data Scientist at Livongo and Teledoc. He has done it all: early stage, late stage, public company. And he deeply understands the nuances of the healthcare market from all angles which is critical for success. While there are many players building healthcare-specific AI capabilities, RadiantGraph is focused on outcomes: The platform is already processing personalization models for more than 3.5 million people, despite launching just last year. Excited to partner with my friend Adam D'Augelli and the great True Ventures again and Morgan Blumberg who has been deep in the healthcare market with me for many years. More on our thesis in the blog below. https://lnkd.in/evDDmC3W

72

4 Comments

Should you sell your practice to a VC-Backed MSO Startup? tldr: - new VC-backed startups are forming MSOs to roll up independent practices - The pitch is physicians receive early liquidity from the roll up and are granted ESOP shares that can be used for retirement - Problem is the use of ESOPs with independent practices is not a new concept and has been used with large group practices since the 70's - ESOPs do not grant full ownership and in order for the shares to be valuable for retirement, the practice needs to run the same if not better post roll up - With VC-backed startups being primarily operated by non-physicians with zero clinical or medical practice experience, the likelihood of this happening is extremely low making the entire concept high risk However, there is a viable path for continued ownership + liquidity for independent practices. Check out the article to learn more. ⤵ https://lnkd.in/gmGvTYwP

7

3 Comments

I recently sat down with Michael Batko, CEO at Startmate and Founder of Puddle Pod for Episode 11 of Insane Ambition. Startmate has invested in 230+ startups, much of it under Michael's leadership, and now has $3.5b in value across its portfolio companies. In this episode, we discussed: - Michael's journey from consulting, then living in the Amazon rainforest, to leading Australia's biggest startup accelerator - The future of Australia's startup ecosystem - The labour government's very stupid plan to make it harder for people to qualify as sophisticated investors (now thankfully shelved) - Startmate City! Startmate's plan to build Australia's first startup city. Probably the most ambitious idea I've ever heard from a startup accelerator. - The balance between visionary thinking and traditional startup advice (think Elon Musk's plan to colonise Mars, vs Y Combinator's problem/customer obsession) - "The Courage to Be Disliked", and its influence on Michael's approach to life and business. Links in the description below 👇

61

4 Comments

99% of tech startup advice is WRONG for Health Tech serving health systems. Here’s what outside advisors or entrepreneurs might tell you… that you should IGNORE: ⛔ 𝗟𝗮𝘂𝗻𝗰𝗵 𝗮 𝗺𝗶𝗻𝗶𝗺𝗮𝗹𝗹𝘆 𝘃𝗶𝗮𝗯𝗹𝗲 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 (𝗠𝗩𝗣) When it comes to tech that touches direct patient care (e.g. digitally guiding patients pre and post-surgery), a MVP isn’t good enough. It has to be fully functional. It has to be safe. It has to be HIPAA / PHIPA-compliant. From Day 1. ⛔ 𝗠𝗼𝘃𝗲 𝗳𝗮𝘀𝘁 𝗮𝗻𝗱 𝗯𝗿𝗲𝗮𝗸 𝘁𝗵𝗶𝗻𝗴𝘀 I like fast… but not if it puts patient safety at risk. It’s not OK if you moved so fast it broke a mission critical feature patients were using to manage their health or providers were using to manage sick patients. Beyond risk of harm, frequently broken products erode trust with patients and providers. Once you lose a patient or provider’s trust, it might be gone forever. ⛔ 𝗗𝗿𝗶𝘃𝗲 𝗽𝗿𝗼𝗱𝘂𝗰𝘁-𝗹𝗲𝗱 𝗴𝗿𝗼𝘄𝘁𝗵 𝘃𝗶𝗮 𝘀𝗲𝗹𝗳-𝗽𝘂𝗿𝗰𝗵𝗮𝘀𝗲 If someone convinces you to “do to healthcare what Dropbox did to businesses with viral bottoms-up viral growth”... I’ll stop you right there. If you’re managing Protected Health Information (PHI), there’s no way an individual clinician can (or should!) just sign up without getting approval from IT/security/privacy. Just won’t happen. ⛔ 𝟭𝟬𝟬% 𝘀𝗲𝗹𝗳-𝘀𝗲𝗿𝘃𝗲 𝘄𝗶𝘁𝗵 𝗻𝗼 𝗰𝗵𝗮𝗻𝗴𝗲 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗵𝗲𝗹𝗽 Maybe this works for the simplest of solutions. But the closer you are to direct clinical care, the more likely you’re dealing with complex patient and provider workflows. E.g. trying to embed remote monitoring workflows and dashboards into the clinician workflow. In those cases, you must invest in Customer Success and professional services to ensure the right change management support is in place to make it successful. Otherwise… expect low user adoption → low impact. ⛔ 𝗚𝗲𝘁 𝘂𝗽 𝗼𝗻 𝘀𝘁𝗮𝗴𝗲 𝗮𝘁 𝗰𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲𝘀 𝘁𝗼 𝗽𝗿𝗼𝗺𝗼𝘁𝗲 𝘆𝗼𝘂𝗿 𝗰𝗼𝗺𝗽𝗮𝗻𝘆 Healthcare folks are WAY more skeptical of industry. This isn’t a general “B2B software-as-a-service” industry where it’s normal for vendors to get up and pitch to each other at Salesforce’s Dreamforce conference. Especially for medical specialty conferences, vendors are almost never on stage. Clinicians want to hear from their clinician peers, not vendors (yes, even if the vendor is a subject matter expert…!) Some exceptions for health-tech focused conferences… still the minority situation though. Focus on making your health system partners successful and earn their public praises. For clarity: if you get a spot on stage... do it! Just don't expect it. 𝗔𝗴𝗿𝗲𝗲 𝗼𝗿 𝗱𝗶𝘀𝗮𝗴𝗿𝗲𝗲? #digitalhealth #healthcareinnovation

219

50 Comments

Here's another fundraising roundup spotted in the healthcare wilds 👀 🍃 ✅ Sword Health raised $130M (new valuation: $3B). ✅ Better Health raised $14M to deploy expanded payer partnerships. ✅ Alzheon, Inc. | Preserving Future Memories raised $100M Series E to advance development & commercialization of its Alzheimer’s treatment. ✅ CinRx Pharma raised $73M to continue its ‘Hub and Spoke’ model of startup formation. ✅ Eko Health raised $41M to scale AI-driven heart and lung disease detection. ✅ Anterior (formerly Co:Helm) secured a $20M Series A to unlock admin efficiencies for healthcare payers. ✅ SamaCare raised a $17M Series B to scale specialty drug prior authorization platform. ✅ Plenful secured a $17M Series A to streamline pharmacy operations with AI-powered workflow automation. ✅ Grayce raised a $10.4M Series A led by Maveron amid a caregiving crisis. ✅ Stitch Employment Services Inc PEO raised $8.75M in seed to support independent medical practices. ✅ Posterity Health secured $6M to fund expansion and technology acceleration. ✅ Sware raised $6M to accelerate life sciences innovation by automating FDA-mandated software validation. ✅ Keragon raised $3M, as announced in @Conno Christou’s LinkedIn post. As always, if I missed you, let me know! Each week I'm spotlighting an innovative healthcare startup. I just ask for a bit more transparency. All submissions are confidential; submit yours here 👇 https://lnkd.in/gF4DrAvJ Looking for more fundraising roundups, alongside healthcare industry news and analysis? Subscribe to Hospitalogy, my 2x/week newsletter. Join 33K+ other investors, executives, and healthcare professionals: https://lnkd.in/g-nfRqW6

40

3 Comments

The most talked about AI x Medical startup Abridge is working to rescue doctors from the never-ending admin grind (which causes burnout and less patient face-time). Abridge's AI listens to patient visits and generates precise medical notes, slashing the clerical workload. Now, doctors can focus on what truly matters: patient care. Major health systems like Yale and Emory are already on board and raving, calling it "life-changing" and "magical." 🔷 A big reason --> Payback of the scribe tool is easy to measure. It supports 14 languages including Haitian Creole, Brazilian Portuguese, and Punjabi. An ongoing criticism of generative AI is that it still has few substantive business applications. This seems to quash that. Question: is a dedicated medical LLM needed to be successful in the space? Or will the huge foundational models (GPT-4o, Google, and Meta) ingest a plethora of medical notes and kill the competition with performance? We're dealing with a fast and furious pace, and today's edge may not be relevant tomorrow. Competitors include Microsoft-owned Nuance Healthcare , Ambience Healthcare, Nabla and Suki. I'm excited to continue to see this field revolutionized. 🌟 #AI #MedTech #Abridge #HealthTech

12

5 Comments

I often meet digital health founders who excitedly share that they’re talking to, in discussions with, or otherwise engaged with a large hospital. Usually, it’s their first potential “big name” client or partner.   Now I don’t want to rain on anyone’s parade, but often I want to tell them: Temper your expectations. You are nowhere near the finish line. Even if you have an LOI, a small contract, or a term sheet in hand.   Just because their venture arm invested doesn’t mean operations will adopt your product.   Just because you found an internal champion doesn’t mean they will make the sale for you.   Just because one unit is paying for it doesn’t mean the rest of the hospital will follow suit.   And just because you sign one banner client doesn’t mean that other hospitals will line up.   While these things are helpful, and the traction is to be celebrated, keep your mind clear and your senses alert. Having multiple conversations is no indicator of progress. A longer relationship offers no promise of success.   Digital health startups tend to run into one of two problems here:   1. Some get stuck in pilot purgatory. Their unpaid or deeply discounted pilot projects go nowhere. Timelines get extended; decisions are delayed. The client demands more data. Often there’s no budget or real intention to pay full price. So sizable contracts never materialize. The carrot continues to dangle.   2. Others basically get turned into a dev shop. They do land paid contracts, but because most of their revenues come from this one client - often an academic medical center - they end up building for very specific use cases and idiosyncratic ways of doing things. Other hospitals don’t need these products.   Ultimately, don’t put too much hope in any one client or partner. Don’t spend all your time and energy on one opportunity, while you could be selling to others. And don’t get enamored by their brand - it doesn’t matter all that much.   #healthtech #digitalhealth #startup #sales #vc

19

4 Comments

#Niche-focused #ventures in #HealthTech, such as those #targeting #underserved areas or #specific health conditions, offer several benefits. They can address gaps in the #healthcare system, provide specialized care, and #potentially integrate into broader #ecosystems for comprehensive healthcare solutions. For example, #JVEDTECHMedovation, could explore #partnerships with #niche #HealthTech startups to enhance offerings in healthcare #innovation.

1

🚀 𝐔𝐧𝐥𝐨𝐜𝐤 𝐒𝐭𝐚𝐫𝐭𝐮𝐩 𝐒𝐮𝐜𝐜𝐞𝐬𝐬 𝐰𝐢𝐭𝐡 𝐔𝐫𝐢 𝐋𝐞𝐯𝐢𝐧𝐞’𝐬 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬! 🚀 Uri Levine, co-founder of Waze and Moovit, shares invaluable lessons in his book “𝘍𝘢𝘭𝘭 𝘪𝘯 𝘓𝘰𝘷𝘦 𝘸𝘪𝘵𝘩 𝘵𝘩𝘦 𝘗𝘳𝘰𝘣𝘭𝘦𝘮, 𝘕𝘰𝘵 𝘵𝘩𝘦 𝘚𝘰𝘭𝘶𝘵𝘪𝘰𝘯.” Key takeaways include the importance of passionately embracing the problem you’re solving, the necessity of customer retention as a marker of product-market fit, and the strategic use of pitch deck slides. He also emphasises the significance of hiring and firing correctly and observing user behaviour to refine your product. These principles can transform your startup journey, ensuring resilience and growth. 🌟 #StartupSuccess #Entrepreneurship #ProductMarketFit #Innovation

5

Everyone in digital health is talking about Telehealth 2.0 right now, but what we really should be talking about is, direct to consumer (D2C) 2.0. Here's why: ⤵ - D2C 1.0 was all about 🍆 pills, hair growth, and birth control, built primarily by D2C startups like Hims or Ro. - D2C 2.0 is going to be all about GLP1's, built by physicians via fractional private practices leveraging social as their main source of distribution. Now, here's where I'm going to make a massive prediction (piggy backing off of Scott Galloway). GLP1's will be what revitalizes primary care, not any of the new CMS payment models, not value based care, not even any of the new tech. Instead it's an old drug with a new rebrand that will save the doctor patient relationship and shift the clinical workforce back to independent practice, and of course it will all powered by AI. TLDR: Every physician in the U.S. will operate a fractional private practice regardless of their FT employment. The default practice type will be D2C and the main objective will be centered on primary care. GLP1s + AI is what gets us there. What do you think of this prediction? ---- Hi, I'm Dr. Mario Amaro, Founder and CEO Ease, and I talk about all things starting, running, and growing a private practice with AI. Follow me, if you are planning to start one or are currently figuring out creative ways to grow one. #PrivatePractice #SelfEmployment #HealthcareOnLinkedin #HeyEase #IndependentTogether #Fintech #Infrastructure #AIinHealthcare #CareDelivery

12

12 Comments

He fell in love with an AI chatbot; then built a $24M healthtech company from scratch. Now clinicians are champions of his product. (but he had 0 healthcare experience) Alex LeBrun, Nabla's CEO, shared a fascinating story with me: Years ago, he was captivated by an AI chatbot named Cybele. This "online dating" experience sparked his passion for AI. Here's how he did it with 0 prior experience and connections in healthcare: 1. Started his own clinic ↳ Invested heavily in creating a learning environment ↳ Operated in two countries to avoid cultural bias ↳ Observed real healthcare processes firsthand ↳ Gained credibility in the industry 2. Found the right partners ↳ Looked beyond conventional healthcare thinking ↳ Avoided those fixated on minor EMR improvements ↳ Built relationships with forward-thinking clinicians 3. Learned from your mistakes ↳ Acknowledged the high cost of building a clinic ↳ Used the experience to gather crucial initial data ↳ Leveraged it to build a strong clinician network 4. Focused on distribution, not just product ↳ Made the product accessible to individual doctors ↳ Let users become product champions 5. Made his product frictionless ↳ Created a simple Chrome extension ↳ Enabled instant trial without complex setup ↳ Designed for overwhelmed, time-poor doctors ↳ Prioritized ease of use over feature overload 6. Adapted the product to individual needs ↳ Recognized diverse documentation styles ↳ Allowed personalization down to user level 7. Built a community of champions ↳ Focused on delighting individual users ↳ Encouraged word-of-mouth promotion ↳ Leveraged doctors' influence in hospitals The key to disrupting healthcare as an outsider is to stay curious, adapt quickly, and solve real problems. PS: Are you an outsider with a bold idea for healthcare? Your fresh perspective might be exactly what the industry needs. Listen to the fascinating episode here: Apple Podcasts: https://hubs.la/Q02CS_300 Spotify Podcasts: https://hubs.la/Q02CTkn60 #CharmHealth #DigitalHealthDisruptors #HealthcareAI #ClinicalAI #AIInnovation #Nabla #AlexLebrun #HealthcareRevolution #Podcast #AIChampions #MedicalTechnology

11

1 Comment